Cargando…

Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs

Human Papillomavirus 16-associated cancer, affecting primarily the uterine cervix but, increasingly, other body districts, including the head–neck area, will long be a public health problem, despite there being a vaccine. Since the virus oncogenic activity is fully ascribed to the viral E6 and E7 on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amici, Carla, Donà, Maria Gabriella, Chirullo, Barbara, Di Bonito, Paola, Accardi, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408665/ https://www.ncbi.nlm.nih.gov/pubmed/32640530 http://dx.doi.org/10.3390/cancers12071803

Ejemplares similares

Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
por: Paolini, Francesca, et al.
Publicado: (2021)

Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells
por: Accardi, Luisa, et al.
Publicado: (2011)

Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16
por: Verachi, F., et al.
Publicado: (2018)

Characterization of antibodies in single-chain format against the E7 oncoprotein of the Human papillomavirus type 16 and their improvement by mutagenesis
por: Donà, Maria Gabriella, et al.
Publicado: (2007)

Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins
por: Di Bonito, Paola, et al.
Publicado: (2006)

Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies
por: Donà, Maria Gabriella, et al.
Publicado: (2021)

Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens
por: Giorgi, Colomba, et al.
Publicado: (2008)

A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models
por: Amici, Carla, et al.
Publicado: (2016)

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
por: Ferrantelli, Flavia, et al.
Publicado: (2019)

Amino-functionalized poly(l-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
por: Di Bonito, Paola, et al.
Publicado: (2015)

Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
por: Di Bonito, Paola, et al.
Publicado: (2019)

Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine
por: de Oliveira, Liliane Maria Fernandes, et al.
Publicado: (2015)

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
por: Di Bonito, Paola, et al.
Publicado: (2017)

Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy
por: Xiong, Chengjie, et al.
Publicado: (2022)

Correction: Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy
Publicado: (2022)

Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China
por: He, Jiaoyu, et al.
Publicado: (2019)

Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series
por: Balestrieri, Maria, et al.
Publicado: (2023)

Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7
por: Hu, Yue, et al.
Publicado: (2020)

Development of Novel Single-Chain Antibodies against the Hydrophobic HPV-16 E5 Protein
por: Monjarás-Ávila, César, et al.
Publicado: (2018)

A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors
por: Wieking, Bryant G., et al.
Publicado: (2012)

Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model
por: Petrone, Linda, et al.
Publicado: (2011)

The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs
por: Chiantore, Maria Vincenza, et al.
Publicado: (2022)

A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection
por: Monroy-García, Alberto, et al.
Publicado: (2011)

Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022)

Establishment of immunoassay for detecting HPV16 E6 and E7 RNA
por: Ding, Sen, et al.
Publicado: (2015)

Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope
por: Olcese, Vanessa A, et al.
Publicado: (2004)

Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice
por: Lee, Tae-Young, et al.
Publicado: (2010)

Fusion of CTLA-4 with HPV16 E7 and E6 Enhanced the Potency of Therapeutic HPV DNA Vaccine
por: Gan, Lili, et al.
Publicado: (2014)

Epitope-preserving magnified analysis of proteome (eMAP)
por: Park, Joha, et al.
Publicado: (2021)

Linear epitope prediction in HPV type 16 E7 antigen and their docked interaction with human TMEM 50A structural model
por: Srivastava, Upasna, et al.
Publicado: (2017)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

HPV16 E6 upregulates Aurora A expression
por: Guo, Yi, et al.
Publicado: (2016)

HPV 16 E7 alters translesion synthesis signaling
por: Wendel, Sebastian O., et al.
Publicado: (2022)

E6/E7 and E6(*) From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
por: Artaza-Irigaray, Cristina, et al.
Publicado: (2019)

Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
por: Morrow, Matthew P, et al.
Publicado: (2016)

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
por: Jiang, Pengfei, et al.
Publicado: (2018)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Differential localization of HPV16 E6 splice products with E6-associated protein
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2005)

A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A*02:01 complex
por: Dao, Tao, et al.
Publicado: (2022)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hfah2qkv6r43sdrd4rglb84vf4